Meletios A Dimopoulos

Meletios A Dimopoulos

UNVERIFIED PROFILE

Are you Meletios A Dimopoulos?   Register this Author

Register author
Meletios A Dimopoulos

Meletios A Dimopoulos

Publications by authors named "Meletios A Dimopoulos"

Are you Meletios A Dimopoulos?   Register this Author

100Publications

2857Reads

7Profile Views

Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis.

Cancer Treat Rev 2019 Sep 6;79:101885. Epub 2019 Aug 6.

Department of Clinical Therapeutics, Alexandra Hospital, Athens, Medical School, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.08.001DOI Listing
September 2019

How I treat Waldenström's Macroglobulinemia.

Blood 2019 Sep 16. Epub 2019 Sep 16.

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019000725DOI Listing
September 2019

Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studies.

Leuk Lymphoma 2019 Aug 26;60(8):1978-1990. Epub 2019 Mar 26.

a Department of Hygiene, Epidemiology and Medical Statistics , School of Medicine, National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1563693DOI Listing
August 2019

Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?

Expert Rev Hematol 2019 Aug 16;12(8):651-663. Epub 2019 Jul 16.

c Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1640115DOI Listing
August 2019

Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.

Int J Cancer 2019 Jul 12;145(2):347-359. Epub 2019 Feb 12.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32109DOI Listing
July 2019

Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?

ESMO Open 2019 25;4(3):e000479. Epub 2019 Jun 25.

Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2018-000479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598554PMC
June 2019

Updates on thrombotic events associated with multiple myeloma.

Expert Rev Hematol 2019 May 14;12(5):355-365. Epub 2019 Apr 14.

a Department of Clinical Therapeutics, School of Medicine , National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1604214DOI Listing
May 2019

Myeloma bone disease: from biology findings to treatment approaches.

Blood 2019 Apr 13;133(14):1534-1539. Epub 2019 Feb 13.

Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-11-852459DOI Listing
April 2019

Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant.

Amyloid 2019 Mar 26;26(1):52-53. Epub 2019 Jan 26.

i Department of Clinical Therapeutics, Alexandra Hospital National and Kapodistrian , University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13506129.2018.1562442DOI Listing
March 2019

A 50-Year-Long Study of Waldenström Macroglobulinemia.

Mayo Clin Proc 2019 Mar;94(3):394-396

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2019.01.021DOI Listing
March 2019

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 Feb 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

Optimizing Immunomodulatory Drug With Proteasome Inhibitor Combinations in Newly Diagnosed Multiple Myeloma.

Cancer J 2019 Jan/Feb;25(1):2-10

From the Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000348DOI Listing
January 2019

Prognostic factors for multiple myeloma in the era of novel therapies.

Expert Rev Hematol 2018 11 26;11(11):863-879. Epub 2018 Oct 26.

a Department of Clinical Therapeutics, School of Medicine, "Alexandra" General Hospital , National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1537776DOI Listing
November 2018

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.

N Engl J Med 2018 11;379(19):1811-1822

From the National and Kapodistrian University of Athens, Athens (M.A.D.); Karol Marcinkowski University of Medical Sciences, Poznań (D.D.), and Silesian Medical University, Katowice (S.G.) - both in Poland; University Hospital, Nantes (P.M.), and Centre Hospitalier Universitaire de Poitiers-La Milétrie, Poitiers (X.L.) - both in France; National Hospital Organization Disaster Medical Center (N.T.) and the Japanese Red Cross Medical Center (K.S.), Tokyo, and Ibaraki Prefectural Central Hospital, Kasama (M.H.) - all in Japan; Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal (R.L.); Heidelberg University Hospital, Heidelberg, Germany (M.S.R.); Dana-Farber Cancer Institute, Boston (P.G.R.); Bristol-Myers Squibb, Princeton, NJ (M.P.M., Y.-M.J., S.G.S., M.R., B.R.); and Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain (J.S.-M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805762
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805762DOI Listing
November 2018

Ibrutinib and Rituximab in Waldenström's Macroglobulinemia.

N Engl J Med 2018 11;379(20):1975-1976

University Hospital of Ulm, Ulm, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809505DOI Listing
November 2018

Managing myeloma with limited resources in the era of novel drugs.

Leuk Lymphoma 2018 10 3;59(10):2269-2270. Epub 2018 Jul 3.

a Department of Clinical Therapeutics, School of Medicine , National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1476692DOI Listing
October 2018

Proteasome Inhibitors in Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 Oct 25;32(5):829-840. Epub 2018 Jul 25.

Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, 80 Vassilisis Sofias Avenue, Athens 11528, Greece.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588183073
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2018.05.011DOI Listing
October 2018

Thalidomide for myeloma: still here?

Lancet Haematol 2018 10;5(10):e439-e440

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026183015
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(18)30154-6DOI Listing
October 2018

Alcohol consumption and risk of hematological malignancies: A meta-analysis of prospective studies.

Int J Cancer 2018 08 30;143(3):486-495. Epub 2018 Mar 30.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31330
Publisher Site
http://dx.doi.org/10.1002/ijc.31330DOI Listing
August 2018

How We Manage Patients with Plasmacytomas.

Curr Hematol Malig Rep 2018 06;13(3):227-235

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-018-0452-z
Publisher Site
http://dx.doi.org/10.1007/s11899-018-0452-zDOI Listing
June 2018

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.

N Engl J Med 2018 Jun 1;378(25):2399-2410. Epub 2018 Jun 1.

From the National and Kapodistrian University of Athens School of Medicine, Athens (M.A.D., E.K.); ASST Grande Ospedale Metropolitano Niguarda, Milan (A.T.), and Città della Salute Hospital and University, Turin (L.O.) - both in Italy; Concord Hospital, University of Sydney, Concord, NSW (J.T.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital, Melbourne, VIC (C.T.) - both in Australia; Hospital Universitario de Salamanca, Salamanca, Spain (R.G.-S.); Ottawa Hospital, University of Ottawa, Ottawa (D.M.), and Royal Victoria Hospital at McGill University Health Centre, Montreal (C.S.) - both in Canada; Département d'Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris (V.L.), Centre Hospitalier Universitaire de Nantes, Nantes (B.M.), and Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille (C.H.) - all in France; Memorial Sloan Kettering Cancer Center, New York (M.L.P.); Colorado Blood Cancer Institute, Denver (J.V.M.); Dana-Farber Cancer Institute, Boston (S.P.T.); Pharmacyclics, Sunnyvale, CA (J.L., Z.S., T.G.); and Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany (C.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802917DOI Listing
June 2018

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent.

Oncotarget 2018 Apr 3;9(25):17797-17809. Epub 2018 Apr 3.

Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, 15784 Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915155PMC
April 2018

Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.

J Clin Oncol 2018 03 17;36(8):728-734. Epub 2018 Jan 17.

David S. Siegel, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; Meletios A. Dimopoulos, National and Kapodistrian University of Athens, Athens, Greece; Heinz Ludwig, Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria; Thierry Facon, Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France; Hartmut Goldschmidt, Heidelberg Medical University and National Center of Tumor Diseases, Heidelberg, Germany; Andrzej Jakubowiak, University of Chicago Medicine, Chicago, IL; Jesus San-Miguel, Clinica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain; Mihaela Obreja and Julie Blaedel, Amgen, Thousand Oaks, CA; and A. Keith Stewart, Mayo Clinic, Scottsdale, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5032DOI Listing
March 2018

Denosumab for myeloma bone disease: ready for prime time?

Lancet Oncol 2018 03 9;19(3):277-278. Epub 2018 Feb 9.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens 11528, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30075-5DOI Listing
March 2018

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.

N Engl J Med 2018 02 12;378(6):518-528. Epub 2017 Dec 12.

From University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona (J.S.-M.) - both in Spain; National and Kapodistrian University of Athens, Athens (M.A.D.); the Institute of Hematology, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna (M. Cavo), and Azienda Ospedaliera "Santa Maria," Terni (A.M.L.) - both in Italy; Japanese Red Cross Medical Center, Department of Hematology, Tokyo (K.S.); University of Chicago Medical Center, Chicago (A.J.); Würzburg University Medical Center, Würzburg, Germany (S.K.); Université Catholique de Louvain (UCL), Centre Hospitalier Universitaire UCL Namur, Yvoir (C.D.), and Janssen Research and Development, Beerse (W.D.) - both in Belgium; Champalimaud Center for the Unknown, Lisbon, Portugal (P.L.); Semmelweis Egyetem, Budapest, Hungary (Z.N.); Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, Ukraine (P.K.); University Hospital Brno, Brno, Czech Republic (L.P.); University Hospitals Birmingham NHS Foundation Trust, Birmingham (M. Cook), and Leicester Royal Infirmary-Haematology, Leicester (M.G.) - both in the United Kingdom; the Department of Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland (S.G.); Clínica de Tratamento E, Cuiaba, Brazil (A.C.); Andrew Love Cancer Centre, Geelong, VIC, Australia (P.C.); Clinic of Professional Pathology, Saratov, Russia (T.S.); the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); LTD "Medinvent" Institute of Health, Tbilisi, Georgia (G.I.); Matsuyama Red Cross Hospital, Matsuyama, Japan (T.F.); Janssen Research and Development, Spring House, PA (C.C., R.C., W.C., M.Q.); and Janssen Research and Development, Raritan, NJ (J.W., H.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714678DOI Listing
February 2018

Carfilzomib for relapsed or refractory multiple myeloma - Authors' reply.

Lancet Oncol 2018 01;19(1):e2

Amgen, Thousand Oaks, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30920-8DOI Listing
January 2018

Pathogenesis of bone disease in multiple myeloma: from bench to bedside.

Blood Cancer J 2018 01 12;8(1). Epub 2018 Jan 12.

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-017-0037-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802524PMC
January 2018

An overview of the role of carfilzomib in the treatment of multiple myeloma.

Expert Opin Pharmacother 2017 Dec 20;18(17):1883-1897. Epub 2017 Nov 20.

a Department of Clinical Therapeutics , Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1404575DOI Listing
December 2017

Disease control should be the goal of therapy for WM patients.

Blood Adv 2017 Nov 28;1(25):2483-2485. Epub 2017 Nov 28.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017005645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729615PMC
November 2017

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.

Leuk Lymphoma 2017 Oct 11;58(10):2304-2309. Epub 2017 Jun 11.

a Department of Clinical Therapeutics , National and Kapodistrian University of Athens, School of Medicine , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1300889DOI Listing
October 2017

Daratumumab combinations: what can we learn?

Blood 2017 08;130(8):957-958

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-07-793349DOI Listing
August 2017

Diagnostic work-up and specific causes of acute kidney injury.

Intensive Care Med 2017 Jun 25;43(6):829-840. Epub 2017 Apr 25.

Division of Cellular and Molecular Medicine, Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven University, Herestraat 49, B3000, Louvain, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00134-017-4799-8DOI Listing
June 2017

Prognosis and risk assessment in AL amyloidosis - There and back again.

Br J Haematol 2017 05;177(3):343-345

Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14587DOI Listing
May 2017

Emerging treatment approaches for myeloma-related bone disease.

Expert Rev Hematol 2017 Mar 29;10(3):217-228. Epub 2017 Jan 29.

a Department of Clinical Therapeutics , National and Kapodistrian University of Athens School of Medicine , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1283213DOI Listing
March 2017

Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.

Expert Opin Investig Drugs 2017 Feb 3;26(2):197-205. Epub 2017 Jan 3.

a Department of Clinical Therapeutics , National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1275561DOI Listing
February 2017

Efficacy and safety of elotuzumab for the treatment of multiple myeloma.

Expert Opin Drug Saf 2017 Feb 11;16(2):237-245. Epub 2017 Jan 11.

a Department of Clinical Therapeutics , National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital , Athens , Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1279603DOI Listing
February 2017